After the introduction of PSA in the late 1980s, the incidence of T1a/b prostate cancers decreased significantly, and in one study of 1648 patients, there was a decrease from 23% to 7% with a greater effect on T1b cancers [26]. Here, KLK3 is linked to prostate carcinoma.